SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Search Videos by Topic or Participant

A unqiue opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

Select Topic:

Browse by Series:

Practical Perspectives on Acute Lymphocytic Leukemia

Acute Lymphoblastic Leukemia: The Future of Treatment

$Role of CAR T-Cell Therapy in Relapsed/Refractory ALL$

Role of CAR T-Cell Therapy in Relapsed/Refractory ALL

$Relapsed/Refractory ALL: Inotuzumab Ozogamicin$

Relapsed/Refractory ALL: Inotuzumab Ozogamicin

$Relapsed/Refractory ALL: Evaluating Novel Agents$

Relapsed/Refractory ALL: Evaluating Novel Agents

$Approaching Treatment for Relapsed/Refractory ALL$

Approaching Treatment for Relapsed/Refractory ALL

MRD-Positive ALL: Personal Approaches to Treatment

ALL: Therapy for Post-Induction MRD-Positivity

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

Next Page >>

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

FDA Approves Blinatumomab for MRD+ ALL

The FDA has granted an accelerated approval to blinatumomab for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.